James O'Leary

2020 - Fusion Pharmaceuticals

In 2020, James O'Leary earned a total compensation of $2.3M as Chief Medical Officer at Fusion Pharmaceuticals.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$158,212
Option Awards$1,790,283
Salary$349,380
Other$5,048
Total$2,327,923

O'Leary received $1.8M in option awards, accounting for 77% of the total pay in 2020.

O'Leary also received $25K in bonus, $158.2K in non-equity incentive plan, $349.4K in salary and $5K in other compensation.

Rankings

In 2020, James O'Leary's compensation ranked 4,867th out of 13,090 executives tracked by ExecPay. In other words, O'Leary earned more than 62.8% of executives.

ClassificationRankingPercentile
All
4,867
out of 13,090
63rd
Division
Manufacturing
1,978
out of 5,618
65th
Major group
Chemicals And Allied Products
783
out of 2,251
65th
Industry group
Drugs
675
out of 1,951
65th
Industry
Biological Products, Except Diagnostic Substances
158
out of 411
62nd
Source: SEC filing on April 27, 2021.

O'Leary's colleagues

We found three more compensation records of executives who worked with James O'Leary at Fusion Pharmaceuticals in 2020.

2020

John Valliant

Fusion Pharmaceuticals

Chief Executive Officer

2020

Eric Burak

Fusion Pharmaceuticals

Chief Scientific Officer

2020

John Crowley

Fusion Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like